- 期刊
- OpenAccess
New Combination for Patients with Latent Tuberculosis Infection: A Pilot Study
摘要
Background: Latent tuberculosis infection (LTBI) is characterized by the presence of immune responses to Mycobacterium tuberculosis without clinical evidence of active TB. LTBI treatment among persons at risk for progression to active disease is an important strategy for TB control and elimination. This prospective observational study aimed to compare the incidences of hepatitis and side effects between a new 2-month combination regimen of isoniazid, rifampin and pyrazinamid (2HRZ) plus excipient and the standard 3-month regimen of isoniazid and rifapentine (3HP) for LTBI treatment in Taiwan. Materials and Methods: Between January 1, 2017, and December 31, 2017, all patients aged ≥20 years diagnosed LTBI were included in the study. Demographic and baseline laboratory assessment of the patients at diagnosis was collected. Eligible individuals were allocated to the 2-month regimen comprising HUEXC030, isoniazid, rifampin, and pyrazinamide (2HRZ) or 3-month regimen with isoniazid and rifapentine (HP). All symptoms and side effects during treatment were recorded. Results: Nineteen patients received the 2-month regimen with HRZ plus HUEXC030, while 23 received the 3-month regimen with HP. The treatment completion rates were 73.7% and 82.6% in the 2- and 3-month regimen groups, respectively. The most common side effects during treatment were fatigue/myalgia/weakness, loss of appetite, and rash. The aspartate aminotransferase, alanine aminotransferase, and total bilirubin levels were similar in both groups after 4 weeks of treatment. Conclusions: This study demonstrates that LTBI patients receiving the 2-month regimen with HRZ plus HUEXC030 experienced similar side effects including hepatitis as patients on the 3-month regimen with HP. This new combination treatment regimen may be an alternative for the treatment of LTBI.
延伸閱讀
- 陳佳銘（2009）。Cognitional study on the infection risk of the pulmonary tuberculosis for the medical personnel〔碩士論文，長榮大學〕。華藝線上圖書館。https://doi.org/10.6833/CJCU.2009.00031
- Liu, C. H., Cheng, Y. W., Chu, P. W., Wang, K. F., Jou, R. W., Huang, Y. F., Chen, C. H., & Chan, P. C. (2016). Drug Resistant Tuberculosis among Tuberculosis Patients and Their Referral Rates. Epidemiology Bulletin, 32(12), 85-86. https://doi.org/10.6525/TEB.20160621.32(12).001
- 周阿綢（2011）。Illness experience in patients with open pulmonary tuberculosis〔碩士論文，長榮大學〕。華藝線上圖書館。https://doi.org/10.6833/CJCU.2011.00165
- 林軒慧（2022）。Relevant Factors for Latent Tuberculosis Infection in Correctional Institution〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/csmu202200176
- 李茹萍、邱艷芬（1998）。Compliance Behavior of Patients with Pulmonary Tuberculosis。護理雜誌，45(1)，63-68。https://doi.org/10.6224/JN.45.1.63